Don't want ads? Subscribe or login now.

Full 3rd Circ. Won't Rethink $45M CareDx False Ad Case

By Emily Field · October 14, 2025, 10:32 PM EDT

The Third Circuit on Tuesday turned down medical testing company CareDx's request to have a full panel mull whether to reinstate a $45 million jury award in a false advertisement case...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

CareDx Inc v. Natera Inc

Case Number

23-2427

Court

Appellate - 3rd Circuit

Nature of Suit

3890 Other Statutory Actions

Date Filed

August 11, 2023

Recent Articles By Emily

October 28, 2025
4th Circ. Overturns Landmark W.Va. Opioid Verdict
October 24, 2025
Pfizer Hit With More Suits Over Depo-Provera
October 23, 2025
Telehealth Ketamine Provider Hit With Wrongful Death Suit
October 20, 2025
Tylenol Maker Tells FDA Not To Add Autism Warning
October 06, 2025
Supplement Co. Sold Soviet-Era Drug As Sleep Aid, Suit Says
September 17, 2025
FDA Says Vape Manufacturer Lying About Marketing Approval
September 05, 2025
Integra Wound Dressing Disfigured Woman's Foot, Suit Says
August 29, 2025
Pfizer Sued Over Depo-Provera Brain Tumor Risks
April 14, 2025
Juul Seeks Ax of Noncompliant Plaintiffs In E-Cig Suits
April 07, 2025
AGs Announce $335M Opioid Deal With Mylan